Citadel Securities has upgraded United Therapeutics Corporation UTHR from Neutral to Add and has raised the price target to $70.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: UpgradesPrice TargetAnalyst RatingsBiotechnologycitadel securitiesHealth CareUnited Therapeutics Corp.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
